MindBio Therapeutics Corp (MBIO)

CSE
Currency in CAD
0.01
0.00(0.00%)
Delayed Data·
MBIO Scorecard
Full Analysis
Significant return over the last week
Trading near 52-week Low
Fair Value
Day's Range
0.010.01
52 wk Range
0.010.06
Key Statistics
Edit
Bid/Ask
0.03 / 0.03
Prev. Close
0.03
Open
0.01
Day's Range
0.01-0.01
52 wk Range
0.01-0.06
Volume
-
Average Volume (3m)
280.52K
1-Year Change
-77.78%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
MBIO Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Stock generally trades with high price volatility

MindBio Therapeutics Corp News & Analysis

Show more

MindBio Therapeutics Corp Company Profile

MindBio Therapeutics Corp., together with its subsidiaries, operates as a clinical stage drug development company in Australasia. The company engages in researching, developing, and testing microdosing of psychedelic substances as a potential treatment for the management of various mental health conditions, such as depression, anxiety, chronic pain, cognitive impairment, post-traumatic stress disorder, panic disorder, and opiate addictions. It also establishes and executes research protocols through formal clinical trials that are facilitated via digital therapeutic platforms; and invests in research for developing treatments for depression, anxiety, PTSD and chronic pain. In addition, the company develops MB22001, which is in Phase 2 clinical trial, for the treatment of major depressive disorder, as well as existential distress, anxiety, and depression associated with advanced stage cancer; and wearable devices to collect biometric data in mental health patients taking psychedelic medicines. MindBio Therapeutics Corp. was incorporated in 2021 and is headquartered in Vancouver, Canada.

Compare MBIO to Peers and Sector

Metrics to compare
MBIO
Peers
Sector
Relationship
P/E Ratio
−3.8x−0.1x−0.5x
PEG Ratio
−0.160.000.00
Price/Book
−1.0x0.8x2.6x
Price / LTM Sales
−9.8x0.7x3.1x
Upside (Analyst Target)
-23.5%48.3%
Fair Value Upside
Unlock20.2%7.6%Unlock

Earnings

Latest Release
May 13, 2025
EPS / Forecast
-0.01 / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

MBIO Income Statement

FAQ

What Is the MindBio Therapeutics (MBIO) Stock Price Today?

The MindBio Therapeutics stock price today is 0.01

What Stock Exchange Does MindBio Therapeutics Trade On?

MindBio Therapeutics is listed and trades on the Canadian Securities Exchange stock exchange.

What Is the Stock Symbol for MindBio Therapeutics?

The stock symbol for MindBio Therapeutics is "MBIO."

What Is the MindBio Therapeutics Market Cap?

As of today, MindBio Therapeutics market cap is 5.46M.

What Is MindBio Therapeutics's Earnings Per Share (TTM)?

The MindBio Therapeutics EPS (TTM) is -0.01.

From a Technical Analysis Perspective, Is MBIO a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has MindBio Therapeutics Stock Split?

MindBio Therapeutics has split 0 times.

How Many Employees Does MindBio Therapeutics Have?

MindBio Therapeutics has 0 employees.

What is the current trading status of MindBio Therapeutics (MBIO)?

As of Jun 13, 2025, MindBio Therapeutics (MBIO) is trading at a price of 0.01, with a previous close of 0.03. The stock has fluctuated within a day range of 0.01 to 0.01, while its 52-week range spans from 0.01 to 0.06.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.